Cognitive impairment and elevated peripheral cytokines in breast cancer patients receiving chemotherapy

Abstract

Background Anthracyclines-based regimen (5-fluorouracil, doxorubicin, and cyclophosphamide (FAC); cyclophosphamide, epirubicin, and 5-fluorouracil [CEF]) and non-anthracycline based regimens (cyclophosphamide, methotrexate, and 5-fluorouracil [CMF]) are widely used as neoadjuvant chemotherapy for breast cancer patients.

Keywords

• Cognitive Dysfunction
• Mental Status and Dementia
• Tests
• Breast Neoplasms
• Neoadjuvant Therapy
• Cytokines
• Disfunção Cognitiva
• Testes de Estado Mental e Demência
• Neoplasias da Mama
• Terapia Neoadjuvante
• Citocinas